Explore the details of the Catalyst Pharmaceuticals, Inc. V. Inventia Healthcare Limited case under case number 1:23-cv-01331 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-01331
Filing Date
Nov 20, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Inventia Healthcare Limited -
SERB SA -
Catalyst Pharmaceuticals, Inc. -

Patents Involved in the Case

This case involves 6 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 20, 2023Summons Issued as to Inventia Healthcare Limited on 11/20/2023. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by SERB SA. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalyst Pharmaceuticals, Inc.. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,626,088 ;10,793,893 ;11,060,128 ;11,268,128 ;11,274,331 ;11,274,332. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/09/2023 & 10/11/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/11/2026. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 11/20/2023)PACER Document
Nov 20, 2023COMPLAINT filed against Inventia Healthcare Limited ( Filing fee $ 402, receipt number ADEDC-4277841.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Civil Cover Sheet)(mpb) (Entered: 11/20/2023)PACER Document
Nov 30, 2023STANDING ORDER REGARDING CASES IN THE U.S. DISTRICT COURT FOR THE DISTRICT OF DELAWARE. (nmg) (Entered: 11/30/2023)PACER Document
Dec 8, 2023NOTICE of Voluntary Dismissal by Catalyst Pharmaceuticals, Inc., SERB SA as to Inventia Healthcare Limited (Viceconte, Christopher) (Entered: 12/08/2023)PACER Document
Dec 8, 2023FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,626,088 ;US 10,793,893 ;US 11,060,128 ;US 11,268,128 ;US 11,274,331 ;US 11,274,332. (apk) (Entered: 12/08/2023)PACER Document
Dec 8, 2023ORDER: Plaintiffs' Complaint, ECF No. 1, is dismissed without prejudice. it is further ORDERED that this case is closed. Signed by Judge Jennifer Choe-Groves on 12/8/2023. (apk) (Entered: 12/08/2023)PACER Document
Nov 22, 2023Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb)PACER Document
Nov 22, 2023Case Reassigned to Judge Jennifer Choe-Groves of the United States Court of International Trade. Please include the initials of the Judge (JCG) after the case number on all documents filed. (rjb)PACER Document